Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 807 results for "pfizer drugmaker pfizer"

Pfizer (PFE) Looking To Reverse Flagging Revenue

Pfizer Inc. ( NYSE:PFE ) is exploring the market to strike a suitable deal after recent changes in its acquisition targets. The company has $33 billion in cash and intends to bring back revenue growth on a year-over-year (YoY) basis through mergers ... Bidness Etc, 13 hours ago

8 images for pfizer drugmaker pfizer, 1 day ago
Asiaone, 1 week ago, 1 day ago, 2 days ago
Kuwait Times, 1 week ago, 1 week ago
Budapest Business Journal, 3 weeks ago
The Rakyat Post, 1 week ago
Pharmaceutical Technology

Pfizer agrees to pay $400m to avoid investor class action lawsuit

Pfizer has agreed to pay around $400m charge for an agreement in principle to resolve a securities class action pending against the company over off-label promotion actions. The decision was disclosed as the company released its fourth-quarter ...
 Pharmaceutical Technology18 hours ago Pfizer to Pay $400M to Avoid Class Action from "Mislead" Shareholders  Pharmaceutical Manufacturing Magazine11 hours ago Pfizer extricates itself from investor suit with $400M settlement  FiercePharma1 day ago
Motley Fool

Pfizer (PFE) Stock Volatile Today After Fourth-Quarter Earnings Beat, Weak 2015 Guidance

By Andrew Meola | 01/27/15 - 09:49 AM EST NEW YORK ( TheStreet ) -- Shares of Pfizer ( PFE - Get Report ) were volatile in early morning trading Tuesday after the pharmaceutical giant forecast a decline in sales in 2015. The largest U.S.
 TheStreet.com1 day ago Pfizer Inc.'s Fourth-Quarter Earnings Hint at Big Things to Come  Motley Fool1 day ago Pfizer net down on lower sales, higher research, legal costs  CNBC1 day ago Pfizer tops 4Q earnings and revenue expectations  FOXBusiness.com1 day ago

Pfizer profit beats estimates; lowers outlook

Drugmaker Pfizer reported stronger-than-expected quarterly revenue results, but forecast a blow to 2015 earnings because of patent expirations and the impact of a stronger dollar. The New York City company, which is the largest U.S. drugmaker, said ...
 USA Today1 day ago Pfizer Sales Suffer From Patent Losses, Stronger Dollar  Forbes.com1 day ago PFIZE : Pfizer  4 Traders1 day ago Novartis, Pfizer and Bristol-Myers hit the gas on R&D last year  FierceBiotech1 day ago

Pfizer beats estimates

Pfizer Inc, the biggest US drugmaker, beat analyst's profit and sales estimates as sales of products including the vaccine Prevnar surpassed expectations. Oct-Dec quarter profit, excluding one-time items, beat by one cent the 53-cent average of 17 ...
 Business Standard India1 day ago Pfizer Beats Earnings Estimates as Vaccine Sales Increase  Bloomberg1 day ago

Pfizer's Deal Desires Move From Pipeline to Products

(Corrects share gains in ninth paragraph.) Pfizer Inc. Chief Executive Officer Ian Read signaled as much Tuesday, saying on a conference call that the company is "biased toward deals with the potential for creating value in the near term." That ...
 BusinessWeek1 day ago Still looking to buy, Pfizer revenue, profit hit by currency-exchange rates  4 Traders1 day ago

Pfizer Forecast Falls Short on Patent Expiration, Strong Dollar

(Bloomberg) -- Pfizer Inc., the biggest U.S. drugmaker, forecast a decline in sales this year as patent expirations and a stronger dollar weigh on revenue. Sales will reach $44.5 billion to $46.5 billion, this year, down from $49.6 billion in 2014, ...
 Washington Post1 day ago

Pressure Lead Pfizer CEO to Approach Teva Pharmaceutical Industries Limited Late Last Year

In pursuit of growth, Pfizer Inc. (PFE) is casting a wide net that included an approach to Teva Pharmaceutical Industries Ltd. (TEVA) late last year, people familiar with the matter said. The Israeli drugmaker immediately rejected Pfizer's ...
 BioSpace2 days ago Pfizer's Deal Hunt Said to Have Included Rebuffed Teva Approach  Bloomberg5 days ago Pfizer's Hunt Said to Have Included Rebuffed Teva Approach  MSN UK3 days ago Pfizer's Deal Hunt Included Rebuffed Teva Approach  BusinessWeek5 days ago
Pharma Letter

Vaccines in poorest countries far too expensive

The international charity Medecins Sans Frontieres urged drugmakers GlaxoSmithKline and Pfizer on Tuesday to slash the price of their pneumococcal vaccines to $5 per child in poor countries. In a report on vaccine prices ahead of an international ...
 NewsHub South Africa6 days ago MSF slams expensive vaccines, urges GSK and Pfizer to cut prices  CNBC1 week ago MSF calls on GSK and Pfizer to slash pneumo vaccine price to $5  Pharma Letter1 week ago MSF slams Glaxo, Pfizer over price of vaccines  Radio Television Hong Kong1 week ago
Nikkei Asian Review

Drugmakers promoting tie-ups with Japanese universities, labs

TOKYO -- Global pharmaceutical companies such as Pfizer, Bayer and GlaxoSmithKline are keeping a keen eye on the work of Japanese universities and laboratories, as they seek partners for joint research and development programs. Bayer ...
 Nikkei Asian Review1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less